|
Chinese
|
3
|
Resverlogix Corp.
|
Jul 13, 2020 01:52PM
|
|
Re: Pfizer's plans for research: sounds like RVX!
|
3
|
Resverlogix Corp.
|
Jan 29, 2020 01:37PM
|
|
Re: Pfizer's plans for research: sounds like RVX!
|
4
|
Resverlogix Corp.
|
Jan 29, 2020 02:11PM
|
|
Why is pps where it is
|
4
|
Resverlogix Corp.
|
Feb 22, 2020 05:13PM
|
|
Re: Tea Leaves
|
4
|
Resverlogix Corp.
|
Jan 24, 2021 09:12AM
|
|
AACR MEETING
|
4
|
Zenith Epigenetics
|
Apr 23, 2020 12:28PM
|
|
Re: Resverlogix Announces Apabetalone Prior to SARS-CoV-2 (COVID-19) Exposure Reduces Viral Infection – Confirms Plans for COVID-19 Clinical Trial
|
4
|
Resverlogix Corp.
|
Dec 22, 2020 08:13AM
|
|
Re: Don't See Us Listed but thought it might interest some
|
4
|
Resverlogix Corp.
|
Mar 11, 2021 10:59AM
|
|
Re: Resverlogix Announces Apabetalone Prior to SARS-CoV-2 (COVID-19) Exposure Reduces Viral Infection – Confirms Plans for COVID-19 Clinical Trial
|
4
|
Resverlogix Corp.
|
Dec 22, 2020 08:42AM
|
|
Price
|
4
|
Resverlogix Corp.
|
Dec 30, 2020 07:48AM
|
|
Hype
|
4
|
Resverlogix Corp.
|
Mar 24, 2020 05:36PM
|
|
Re: Two big questions for December if there is no good deal announced, as we certainly don't need another Israeli deal IMO.
|
4
|
Resverlogix Corp.
|
Nov 25, 2020 01:09PM
|
|
Re: Back to the drawing board for triple-negative breast cancer targets, researchers propose new combo approach.
|
4
|
Zenith Epigenetics
|
Apr 01, 2020 03:58PM
|
|
Re buy out
|
4
|
Resverlogix Corp.
|
Aug 22, 2020 12:00PM
|
|
Re: Apabetalone publication in "Current Opinion in Nephrology & Hypertension"
|
4
|
Resverlogix Corp.
|
Jan 30, 2020 11:22AM
|
|
C19
|
4
|
Resverlogix Corp.
|
Apr 14, 2020 08:24AM
|
|
Re: Prostate Trial
|
4
|
Zenith Epigenetics
|
Apr 24, 2020 11:25AM
|
|
Re: the happening/not happening scale
|
4
|
Resverlogix Corp.
|
Apr 09, 2020 06:18PM
|
|
Re: The last couple of minutes of Tax Loss Selling
|
4
|
Resverlogix Corp.
|
Dec 30, 2019 12:19PM
|
|
Re: The Big Day tomorrow...
|
4
|
Resverlogix Corp.
|
Jan 27, 2021 10:31AM
|
